Patients News | pharmaphorum

News

Akili says ADHD game works in adults too

Akili Interactive has revealed the findings of a trial of its digital therapeutic (DTx) for attention-deficit hyperactivity disorder (ADHD) in adults, suggesting it may be

News

FDA sets out its thinking on decentralised clinical trials

The FDA has issued draft guidance on the use of decentralised clinical trials (DCTs), which are increasingly being used by the pharma industry to tackle issues, such as di

News

Forget the doctor, why not just ask ChatGPT?

In a study of random patient questions drawn from the Reddit social media platform, people responded more positively to answers provided by

News

NICE backs use of Gilead/Kite CAR-T via Cancer Drugs Fund

A pair of new guidance documents from UK cost-effectiveness authority NICE could see hundreds of more blood cancer patients eligible for treatment with CAR-T therapies fro

News

Single market at heart of EU plans for pharma reform

The European Commission’s long-promised revamp of pharmaceutical legislation is finally unveiled, and it’s ambitious to say the least.

News

Nerve damage-tracking pen to be used in CAR-T patients

Nerve damage is a recognised side effect of some CAR-T therapies for cancer, and one that could be spotted early using a pen device developed by UK company Manus Neurodyna

Akili says ADHD game works in adults too

FDA sets out its thinking on decentralised clinical trials

Forget the doctor, why not just ask ChatGPT?

NICE backs use of Gilead/Kite CAR-T via Cancer Drugs Fund

Single market at heart of EU plans for pharma reform

Nerve damage-tracking pen to be used in CAR-T patients

Merck rare tumour drug Ezmekly backed for NHS use

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks